TVGN — Tevogen Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-01-05.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-10 | Feike Jeffrey L. Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-07-10 | Goh Keow Lin Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-07-10 | Desai Kirti Chief Financial Officer | Grant or award | 40.0K | 0.00 | 0 |
| 2026-07-10 | Patton Curtis L. Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-07-10 | Saadi Ryan H. Chief Executive Officer | Grant or award | 1.2M | 0.00 | 0 |
| 2026-07-10 | Sordillo Victor J. Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-07-10 | PODLOGAR SUSAN M Director | Grant or award | 40.0K | 0.00 | 0 |
| 2026-03-13 | Flomenberg Neal See Remarks | Open-market sale | 501 | 6.40 | 3.2K |
| 2026-03-11 | Flomenberg Neal See Remarks | Open-market sale | 452 | 7.26 | 3.3K |
| 2026-03-10 | Flomenberg Neal See Remarks | Open-market sale | 19 | 7.75 | 147 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 150.3K | 33.2K |
| BlackRock, Inc. | 110.3K | 24.4K |
| MORGAN STANLEY | 78.3K | 17.3K |
| GEODE CAPITAL MANAGEMENT, LLC | 71.1K | 15.7K |
| DEUTSCHE BANK AG\ | 69.3K | 15.3K |
| FMR LLC | 45.9K | 10.2K |
| Russell Investments Group, Ltd. | 26.2K | 5.8K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 20.5K | 4.5K |
| UBS Group AG | 16.1K | 3.6K |
| VANGUARD FIDUCIARY TRUST CO | 6.2K | 1.4K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| DEF 14A | 2026-08-03 | 2026-08-03 | on EDGAR ↗ |
| 8-K | 2026-07-30 | 2026-07-29 | on EDGAR ↗ |
| PRE 14A | 2026-07-23 | 2026-07-23 | on EDGAR ↗ |
| SCHEDULE 13D/A | 2026-07-14 | — | on EDGAR ↗ |
| 4 | 2026-07-10 | 2026-07-10 | on EDGAR ↗ |
| 4 | 2026-07-10 | 2026-07-10 | on EDGAR ↗ |
| 4 | 2026-07-10 | 2026-07-10 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Tevogen Inc. (TVGN) filed form 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about TVGN
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →